Current practice and provision of oncoplastic breast-conserving surgery in the UK: results of the ANTHEM national practice questionnaire Charlotte DaviesLisa Whiskeron behalf of the ANTHEM Study Steering Group Preclinical study 22 May 2023 Pages: 163 - 170
A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer Yu FanXiaorong ZhongHong Zheng Preclinical study Open access 18 May 2023 Pages: 171 - 182
Classification of breast tumors by using a novel approach based on deep learning methods and feature selection Nizamettin KutluerOzgen Arslan SolmazHuseyin Eristi Preclinical study 21 May 2023 Pages: 183 - 192
Organoid models derived from patients with malignant phyllodes tumor of the breast Xinyu ChuMing WuJinsong He Preclinical Study 19 May 2023 Pages: 193 - 201
Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVATTL Pro 3 Study María Dolores Martín-SalvagoMagdalena SanchoBegoña Vieites Clinical trial Open access 23 May 2023 Pages: 203 - 215
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast Utsav JoshiPravash BudhathokiSiddhartha Yadav Epidemiology 21 May 2023 Pages: 217 - 224
Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival Neeraj KumarPeter H. GannAmit Sethi Epidemiology Open access 20 May 2023 Pages: 225 - 235
Breast cancer risk prediction combining a convolutional neural network-based mammographic evaluation with clinical factors Alissa MichelVicky RoKatherine D. Crew Epidemiology 20 May 2023 Pages: 237 - 245
Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy Sudheer VemuruJin HuangSarah Tevis Epidemiology 26 May 2023 Pages: 247 - 256
The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study Karolina BrylSusan ChimonasJun J. Mao Epidemiology 24 May 2023 Pages: 257 - 264
Women with metastatic breast cancer don't just follow step-count trends, they exceed them: an exploratory study Maxime CaruSaeed AbdullahKathryn H. Schmitz Brief Communication 25 May 2023 Pages: 265 - 270
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer M. K. BosS. W. LamS. Sleijfer Original Laboratory Investigation Open access 25 May 2023 Pages: 271 - 279
Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy Ying ZhouJinmei ZhouTao Wang Original Laboratory Investigation 25 May 2023 Pages: 281 - 291
Vessel size as a marker of survival in estrogen receptor positive breast cancer Vladan MilosevicReidunn J. EdelmannArne Östman Original Laboratory Investigation Open access 24 May 2023 Pages: 293 - 304
